Int. Journal of Drug R&D
USA Edition : EU Edition : PR Edition
Locum International Press.
Issues # 01 - 08
Eight issues per year
The International Journal of Drug R&D
Designed for pharmaceutical researchers in the NDA CMC (chemistry manufacture
control) and Generic Drug Development sectors including detailed aspects
of NDA/ANDA (bio/pivotal) and commercial validation batch manufacture.
Reviews key CMC processes and structured drug design programs. Anticipate
future harmonized drug design requirements. Dramatically improve your
company's R&D new pipeline performance regardless of firm size.
Highlights new drug design requirement and how to use a development partner
to speed product development and reduce risk. A forward looking peer reviewed
journal that is relevant from the bench to the boardroom. Addresses the
most up-to-date developments in CMC technology.
An essential first read for drug development chemists and scientists
working in CMCs area of NDAs and ANDAs. An excellent source of know-how
information on the nuts-and-bolts of drug development. Delivers authoritative
perspective on the future of drug research and development.
Describes R&D approaches being adopted in a clear and user friendly
way. Decision trees making R&D decisions analysis easier across the
pipeline for increased productivity. Accelerated time-to-market programs.
Enhanced bottom-line performance with key know-how on CDER and OGDs expectations
of the bio/pivotal batch manufacture highlighting side-by-side batch comparisons
between bio/pivotal regulatory batch and commercial validation batches.
A comprehensive new forum filled with essential drug development data
associated with CMC and on dosage form, preformulation techniques, scale-up,
drug development, process development, dosage specific validation procedures,
quality assurance and control.
Each issue targets a specific dosage form detailing developmental and
scale-up topics. Each Journal issue contains material dedicated to the
review of a specific dosage form and specific development and scale-up
This Journal features drug development articles, technical reviews, procedural
checklists, SOPs and Side-by-Side specification comparisons of all major
dosage form parameters ranging from A (actives) to V (validation).
A primary source Journal to fill the ever changing information gap for
CMC and Generic Drug Development. The Journal emphasizes a multidisciplinary
approach between all key development and production departments.
80 - 95 pp illustrated
b/w & color
Subscription - Print
$1499.00 - Print Edition (single-user airmail print edition worldwide)
$1699.00 - Corporate single license single pharma campus - (Print)
$1999.00 - Corporate multiple-user license - (Print edition maximizes
distribution and readership for multiple pharma campus).